1. Home
  2. ADPT vs VERX Comparison

ADPT vs VERX Comparison

Compare ADPT & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$14.91

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Vertex Inc.

VERX

Vertex Inc.

HOLD

Current Price

$15.30

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
VERX
Founded
2009
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
ADPT
VERX
Price
$14.91
$15.30
Analyst Decision
Strong Buy
Buy
Analyst Count
9
14
Target Price
$17.78
$28.29
AVG Volume (30 Days)
1.6M
2.8M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
N/A
N/A
Revenue
$276,976,000.00
$748,444,000.00
Revenue This Year
$3.98
$12.78
Revenue Next Year
$22.72
$11.61
P/E Ratio
N/A
$302.25
Revenue Growth
54.77
12.25
52 Week Low
$6.26
$11.87
52 Week High
$20.76
$42.44

Technical Indicators

Market Signals
Indicator
ADPT
VERX
Relative Strength Index (RSI) 36.46 51.18
Support Level $12.32 $11.91
Resistance Level $17.91 $20.44
Average True Range (ATR) 0.74 0.73
MACD -0.01 0.48
Stochastic Oscillator 3.89 86.79

Price Performance

Historical Comparison
ADPT
VERX

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

Share on Social Networks: